Patenting transgenic human embryos: a nonuse cost perspective.
D000818:Animals; D030801:Animals, Genetically Modified; D033421:Beginning of Human Life; D002678:Chimera; D004274:DNA, Recombinant; D004467:Economics; D033041:Embryo Research; D004622:Embryo, Mammalian; D005053:Eugenics; D005818:Genetic Engineering; D015316:Genetic Therapy; D005854:Germ Cells; D006801:Humans; D007603:Jurisprudence; D019369:Life; D008829:Microbiology; D009042:Motivation; D030781:Organisms, Genetically Modified; D010330:Patents as Topic; D011640:Public Policy; D012106:Research; D012306:Risk; D018570:Risk Assessment; D014481:United States; D026712:Value of Life
Biomedical and Behavioral Research; Genetics and Reproduction; Legal Approach; Patent and Trademark Office